YearStart,YearEnd,LocationAbbr,LocationDesc,DataSource,Topic,Question,Response,DataValueUnit,DataValueType,DataValue,DataValueAlt,DataValueFootnoteSymbol,DatavalueFootnote,LowConfidenceLimit,HighConfidenceLimit,StratificationCategory1,Stratification1,StratificationCategory2,Stratification2,StratificationCategory3,Stratification3,GeoLocation,ResponseID,LocationID,TopicID,QuestionID,DataValueTypeID,StratificationCategoryID1,StratificationID1,StratificationCategoryID2,StratificationID2,StratificationCategoryID3,StratificationID3
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.4,48.4,,,41.3,55.6,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.0,81.0,,,70.3,88.5,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.5,31.5,,,24.3,39.7,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.7,6.7,,,5.4,8.5,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.6,37.6,,,31.5,44.2,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,4.9,4.9,,,3.1,7.6,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.4,88.4,,,82.2,92.6,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.3,82.3,,,70.5,90.1,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.8,54.8,,,46.7,62.5,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.5,7.5,,,5.8,9.6,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.3,72.3,,,59.9,82.0,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.0,81.0,,,66.2,90.2,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.3,67.3,,,55.7,77.1,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.2,41.2,,,34.4,48.2,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.2,34.2,,,25.5,44.1,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.7,84.7,,,73.4,91.8,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.3,12.3,,,10.3,14.7,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.3,38.3,,,24.1,54.8,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.0,49.0,,,39.9,58.1,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.1,29.1,,,16.5,46.1,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.9,26.9,,,15.3,42.9,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,57.9,57.9,,,39.1,74.6,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.5,69.5,,,56.5,80.0,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,56.9,56.9,,,36.5,75.2,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,53.5,53.5,,,35.5,70.7,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.5,25.5,,,19.1,33.0,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.1,64.1,,,51.9,74.7,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.5,12.5,,,10.7,14.5,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.9,5.9,,,4.6,7.6,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.3,12.3,,,10.6,14.4,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.4,40.4,,,27.8,54.5,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,62.2,62.2,,,49.8,73.2,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,25.6,25.6,,,14.1,41.8,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.9,5.9,,,4.6,7.6,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,26.2,46.4,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.3,26.3,,,15.7,40.5,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.0,39.0,,,27.2,52.3,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.5,74.5,,,60.8,84.6,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.8,75.8,,,63.3,85.1,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.6,37.6,,,28.0,48.4,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.8,5.8,,,4.7,7.2,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.7,43.7,,,35.0,52.8,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.8,13.8,,,12.1,15.8,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.0,40.0,,,31.3,49.3,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.3,86.3,,,75.7,92.7,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,57.3,57.3,,,40.4,72.6,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.8,48.8,,,39.4,58.3,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.8,13.8,,,11.9,15.9,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.8,64.8,,,48.1,78.6,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.2,80.2,,,64.9,89.9,Gender,Female,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AL,Alabama,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.8,28.8,,,21.6,37.3,Gender,Female,,,,,POINT (-86.63186076199969 32.84057112200048),,1,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.1,34.1,,,22.1,48.5,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AK,Alaska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.9,5.9,,,4.7,7.3,Gender,Male,,,,,POINT (-147.72205903599973 64.84507995700051),,2,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.6,40.6,,,27.5,55.3,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,63.4,63.4,,,51.7,73.6,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.2,84.2,,,74.0,90.9,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.0,78.0,,,61.5,88.7,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.8,6.8,,,5.5,8.5,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,24.6,24.6,,,16.1,35.6,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.5,28.5,,,18.7,41.0,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.4,37.4,,,26.1,50.3,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,26.8,46.1,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.9,80.9,,,67.4,89.6,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.1,64.1,,,47.8,77.7,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.7,36.7,,,26.9,47.6,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.1,65.1,,,48.7,78.6,Gender,Male,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.4,11.4,,,9.5,13.7,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.3,34.3,,,26.2,43.5,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.4,84.4,,,74.1,91.1,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.5,38.5,,,28.9,49.0,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.1,11.1,,,9.3,13.1,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AR,Arkansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,63.6,63.6,,,51.7,74.0,Gender,Female,,,,,POINT (-92.27449074299966 34.74865012400045),,5,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.3,38.3,,,31.8,45.2,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.1,36.1,,,30.6,41.9,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.2,36.2,,,30.5,42.3,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.3,12.3,,,11.1,13.6,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.2,65.2,,,56.2,73.3,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.3,83.3,,,74.9,89.3,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.2,72.2,,,56.5,83.8,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.1,83.1,,,67.3,92.1,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.1,38.1,,,30.1,46.9,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.5,6.5,,,5.6,7.5,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.3,30.3,,,22.6,39.3,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.6,6.6,,,5.7,7.6,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.3,83.3,,,68.2,92.0,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.2,72.2,,,56.6,83.8,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,30.0,46.0,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.2,12.2,,,11.0,13.4,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,63.2,63.2,,,53.6,71.9,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.3,81.3,,,71.0,88.5,Gender,Female,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,AZ,Arizona,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.8,29.8,,,22.4,38.4,Gender,Male,,,,,POINT (-111.76381127699972 34.865970280000454),,4,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.7,10.7,,,9.4,12.2,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.1,80.1,,,65.3,89.7,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.2,67.2,,,50.1,80.7,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.3,31.3,,,23.8,39.9,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.8,33.8,,,26.1,42.4,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.7,80.7,,,66.2,89.9,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.2,69.2,,,54.4,80.8,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.1,38.1,,,30.4,46.4,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.3,33.3,,,25.8,41.6,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.8,66.8,,,49.1,80.8,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.1,44.1,,,36.6,52.0,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.5,69.5,,,54.6,81.1,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,28.9,45.1,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.9,6.9,,,5.2,9.0,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,65.1,65.1,,,45.3,80.7,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.6,10.6,,,9.3,12.0,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.9,6.9,,,5.9,8.2,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.9,6.9,,,5.9,8.1,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.7,42.7,,,35.5,50.2,Gender,Female,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CA,California,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.7,64.7,,,46.7,79.3,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,CA,California,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.6,32.6,,,24.3,42.2,Gender,Male,,,,,POINT (-120.99999953799971 37.63864012300047),,6,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.0,72.0,,,54.9,84.4,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.8,13.8,,,12.6,15.0,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.3,43.3,,,37.7,49.0,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.4,55.4,,,50.0,60.6,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.1,87.1,,,75.9,93.5,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.4,42.4,,,36.7,48.3,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.3,77.3,,,63.9,86.7,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.6,54.6,,,49.3,59.7,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.8,75.8,,,65.2,84.0,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,89.5,89.5,,,80.4,94.6,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.7,13.7,,,12.6,15.0,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.6,76.6,,,66.7,84.2,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,89.4,89.4,,,80.2,94.6,Gender,Female,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.7,49.7,,,42.7,56.8,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.1,7.1,,,6.3,8.0,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.1,7.1,,,6.3,8.0,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.8,32.8,,,26.2,40.1,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.5,87.5,,,78.0,93.2,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.4,31.4,,,25.1,38.6,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CO,Colorado,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.3,49.3,,,42.3,56.2,Gender,Male,,,,,POINT (-106.13361092099967 38.843840757000464),,8,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,57.2,57.2,,,41.0,72.0,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.6,86.6,,,77.1,92.6,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.7,7.7,,,6.6,9.0,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.9,83.9,,,70.8,91.8,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.4,82.4,,,67.4,91.4,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.1,13.1,,,11.8,14.6,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.8,7.8,,,6.7,9.2,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.0,52.0,,,42.2,61.6,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.5,84.5,,,71.5,92.2,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.6,80.6,,,64.7,90.3,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,25.7,25.7,,,18.1,35.2,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.4,13.4,,,12.0,15.0,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.0,54.0,,,47.4,60.4,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.6,33.6,,,27.0,41.0,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.0,25.0,,,18.0,33.5,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.9,50.9,,,42.5,59.3,Gender,Male,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.6,33.6,,,27.5,40.2,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,57.2,57.2,,,42.1,71.1,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.6,86.6,,,77.6,92.3,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,CT,Connecticut,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.1,54.1,,,47.6,60.6,Gender,Female,,,,,POINT (-72.64984095199964 41.56266102000046),,9,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.4,73.4,,,53.7,86.7,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.2,78.2,,,58.3,90.2,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.4,26.4,,,19.8,34.3,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.0,15.0,,,12.6,17.7,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,24.2,24.2,,,17.2,32.8,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.9,52.9,,,42.4,63.0,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,53.5,53.5,,,42.9,63.9,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.8,14.8,,,12.6,17.4,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,20.6,20.6,,,12.1,32.8,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.5,43.5,,,30.4,57.6,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.1,8.1,,,6.2,10.7,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.0,8.0,,,6.1,10.3,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.3,44.3,,,29.6,60.1,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,20.9,20.9,,,12.0,33.8,Gender,Male,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.0,69.0,,,49.7,83.4,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DC,District of Columbia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.6,79.6,,,60.8,90.7,Gender,Female,,,,,POINT (-77.036871 38.907192),,11,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.0,13.0,,,10.9,15.5,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.2,31.2,,,17.0,50.2,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,91.4,91.4,,,82.1,96.1,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.1,26.1,,,18.0,36.4,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,52.7,52.7,,,42.0,63.2,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.1,7.1,,,5.3,9.4,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.5,38.5,,,24.7,54.5,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.0,32.0,,,19.4,47.9,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.4,38.4,,,23.7,55.5,Gender,Male,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.3,73.3,,,56.9,85.2,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.7,29.7,,,21.6,39.3,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.0,54.0,,,43.9,63.8,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.8,88.8,,,76.0,95.2,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.6,12.6,,,10.7,14.6,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,DE,Delaware,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.8,74.8,,,59.7,85.7,Gender,Female,,,,,POINT (-75.57774116799965 39.008830667000495),,10,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,,,-,No data available,,,Gender,Female,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,FL,Florida,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,-,No data available,,,Gender,Male,,,,,POINT (-81.92896053899966 28.932040377000476),,12,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.2,81.2,,,71.0,88.4,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,66.7,66.7,,,55.8,76.0,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.7,66.7,,,55.7,76.2,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.6,82.6,,,73.6,89.0,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.5,5.5,,,4.4,6.9,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.6,28.6,,,18.7,41.2,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.3,35.3,,,24.1,48.4,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,4.9,4.9,,,3.1,7.7,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,4.5,4.5,,,2.8,7.1,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.5,5.5,,,4.4,6.8,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.4,32.4,,,22.9,43.7,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.8,42.8,,,32.6,53.8,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.9,12.9,,,11.5,14.5,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,29.2,44.6,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.4,38.4,,,31.4,46.0,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,4.2,4.2,,,2.7,6.6,Gender,Male,,,,,POINT (144.793731 13.444304),,66,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.1,39.1,,,32.3,46.4,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.2,13.2,,,11.6,14.9,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GU,Guam,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (144.793731 13.444304),,66,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,GA,Georgia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.3,35.3,,,29.0,42.1,Gender,Female,,,,,POINT (-83.62758034599966 32.83968109300048),,13,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.2,81.2,,,63.5,91.5,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.4,75.4,,,63.6,84.3,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.7,10.7,,,9.4,12.1,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.3,40.3,,,33.2,47.8,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.0,28.0,,,20.9,36.4,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.6,31.6,,,22.5,42.4,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.6,81.6,,,63.5,91.9,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,63.1,63.1,,,44.3,78.6,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.6,10.6,,,9.3,12.1,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.4,51.4,,,40.5,62.2,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.6,5.6,,,4.7,6.7,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.1,64.1,,,45.5,79.2,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.9,67.9,,,52.3,80.4,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.9,30.9,,,20.8,43.1,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.7,49.7,,,38.7,60.6,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.5,39.5,,,32.7,46.8,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,27.2,27.2,,,20.5,35.1,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.8,67.8,,,51.0,81.0,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.3,75.3,,,63.6,84.1,Gender,Female,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,HI,Hawaii,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.6,5.6,,,4.6,6.7,Gender,Male,,,,,POINT (-157.85774940299973 21.304850435000446),,15,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.2,80.2,,,68.1,88.4,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.9,80.9,,,69.0,88.9,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.4,11.4,,,10.2,12.8,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.0,48.0,,,40.8,55.3,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.8,49.8,,,42.8,56.9,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.8,6.8,,,5.9,7.9,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,92.3,92.3,,,85.0,96.2,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.7,74.7,,,63.8,83.2,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.9,48.9,,,40.5,57.4,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,92.3,92.3,,,85.0,96.2,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.6,40.6,,,32.6,49.2,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.7,74.7,,,63.9,83.2,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.3,80.3,,,68.6,88.4,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.8,6.8,,,5.9,7.8,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.7,42.7,,,33.9,51.9,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.3,81.3,,,69.7,89.1,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.0,50.0,,,41.4,58.6,Gender,Male,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.0,49.0,,,42.1,55.8,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.9,11.9,,,10.6,13.3,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IA,Iowa,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.3,46.3,,,38.9,53.8,Gender,Female,,,,,POINT (-93.81649055599968 42.46940091300047),,19,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.0,7.0,,,6.0,8.2,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.1,76.1,,,58.4,87.8,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.9,23.9,,,16.3,33.5,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.9,32.9,,,24.2,43.0,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,63.0,63.0,,,47.4,76.3,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.0,75.0,,,65.2,82.8,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.9,86.9,,,78.4,92.4,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,24.4,42.9,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.5,12.5,,,11.1,13.9,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,24.8,24.8,,,16.9,34.9,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,31.3,44.6,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.9,35.9,,,28.8,43.7,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.2,75.2,,,66.1,82.6,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.6,87.6,,,79.6,92.8,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.4,12.4,,,11.1,14.0,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.1,7.1,,,6.1,8.3,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.0,78.0,,,59.6,89.5,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,63.7,63.7,,,47.7,77.2,Gender,Male,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.8,37.8,,,30.8,45.3,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ID,Idaho,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.9,37.9,,,31.3,45.0,Gender,Female,,,,,POINT (-114.3637300419997 43.682630005000476),,16,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.5,26.5,,,16.1,40.5,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.9,85.9,,,72.8,93.3,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.0,43.0,,,30.9,56.0,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.0,45.0,,,31.3,59.6,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.6,45.6,,,34.1,57.5,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.5,75.5,,,51.5,89.9,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.1,78.1,,,58.5,90.1,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.5,6.5,,,5.0,8.6,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.4,6.4,,,4.8,8.5,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.6,80.6,,,62.2,91.3,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.8,10.8,,,9.0,13.0,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.0,86.0,,,74.2,92.9,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.0,11.0,,,9.0,13.5,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.2,45.2,,,33.6,57.4,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.8,41.8,,,30.8,53.8,Gender,Female,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.7,43.7,,,29.4,59.1,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IL,Illinois,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.4,28.4,,,16.6,44.3,Gender,Male,,,,,POINT (-88.99771017799969 40.48501028300046),,17,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.4,43.4,,,38.0,48.9,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.8,34.8,,,29.7,40.3,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,89.2,89.2,,,83.6,93.1,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.7,6.7,,,5.8,7.8,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.8,67.8,,,58.6,75.8,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.9,37.9,,,30.4,46.1,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.1,67.1,,,58.4,74.7,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.7,6.7,,,5.8,7.8,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,27.5,44.7,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.8,13.8,,,12.6,15.0,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.8,36.8,,,28.8,45.6,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.5,75.5,,,62.9,84.9,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.9,36.9,,,28.0,46.9,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.7,78.7,,,65.1,88.0,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.9,13.9,,,12.8,15.2,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.1,42.1,,,36.9,47.6,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.8,32.8,,,27.7,38.2,Gender,Female,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.4,79.4,,,66.9,88.1,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,IN,Indiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.3,74.3,,,61.4,84.0,Gender,Male,,,,,POINT (-86.14996019399968 39.766910452000445),,18,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.4,32.4,,,26.9,38.4,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.1,38.1,,,32.8,43.7,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.2,41.2,,,37.0,45.5,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.8,49.8,,,45.5,54.1,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.0,8.0,,,7.3,8.8,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.6,78.6,,,70.5,85.0,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.5,84.5,,,77.3,89.7,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.9,70.9,,,63.2,77.6,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.7,80.7,,,73.0,86.6,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.5,51.5,,,47.1,55.9,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.1,13.1,,,12.2,14.0,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.5,44.5,,,40.0,49.0,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.0,8.0,,,7.3,8.9,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.4,33.4,,,27.8,39.5,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.6,85.6,,,78.3,90.7,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.4,70.4,,,62.9,77.0,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.1,80.1,,,72.3,86.1,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.6,37.6,,,32.2,43.2,Gender,Male,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.7,80.7,,,73.2,86.5,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,KS,Kansas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.3,13.3,,,12.4,14.3,Gender,Female,,,,,POINT (-98.20078122699965 38.34774030000045),,20,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,60.8,60.8,,,44.1,75.4,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.1,69.1,,,55.2,80.2,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.5,41.5,,,34.0,49.4,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.0,34.0,,,26.9,41.8,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.3,8.3,,,7.0,9.8,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.5,69.5,,,55.7,80.5,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,26.9,47.5,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.9,29.9,,,21.8,39.6,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.3,12.3,,,10.7,14.1,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.1,15.1,,,13.3,17.2,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.7,81.7,,,67.1,90.7,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.1,8.1,,,6.8,9.5,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.2,71.2,,,57.2,82.0,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.6,39.6,,,29.2,51.0,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.5,30.5,,,22.1,40.4,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.9,14.9,,,13.2,16.9,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.8,82.8,,,69.9,90.9,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.3,69.3,,,52.2,82.3,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.5,31.5,,,24.6,39.4,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,59.7,59.7,,,42.1,75.1,Gender,Male,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,KY,Kentucky,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.4,40.4,,,32.7,48.6,Gender,Female,,,,,POINT (-84.77497104799966 37.645970271000465),,21,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.5,35.5,,,27.7,44.1,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.0,43.0,,,34.2,52.2,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.6,8.6,,,7.5,9.9,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.7,14.7,,,13.4,16.0,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,89.8,89.8,,,72.7,96.7,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.4,12.4,,,10.7,14.4,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.3,81.3,,,70.0,89.0,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,92.7,92.7,,,80.5,97.5,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.3,82.3,,,71.6,89.6,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,22.9,46.6,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.9,34.9,,,27.2,43.5,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.8,38.8,,,30.8,47.4,Gender,Female,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.5,33.5,,,22.7,46.3,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.9,6.9,,,5.5,8.7,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.9,6.9,,,5.5,8.7,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,LA,Louisiana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,16.1,16.1,,,8.8,27.4,Gender,Male,,,,,POINT (-92.44568007099969 31.31266064400046),,22,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.1,75.1,,,67.5,81.5,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.5,12.5,,,11.4,13.6,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.5,88.5,,,82.5,92.7,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,61.6,61.6,,,55.1,67.7,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.2,72.2,,,56.6,83.8,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,95.5,95.5,,,91.3,97.7,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.9,5.9,,,5.2,6.8,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.9,29.9,,,22.5,38.4,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.5,44.5,,,36.1,53.2,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.9,34.9,,,28.2,42.2,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.7,7.7,,,6.7,8.9,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.2,46.2,,,40.6,52.0,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.6,12.6,,,11.5,13.8,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.0,33.0,,,27.7,38.7,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.7,7.7,,,6.6,8.8,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,61.1,61.1,,,53.1,68.7,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.7,37.7,,,33.9,41.8,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.4,72.4,,,56.5,84.1,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.2,74.2,,,66.4,80.7,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,94.9,94.9,,,90.2,97.4,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.7,87.7,,,80.7,92.4,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.3,29.3,,,21.6,38.4,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.2,85.2,,,72.9,92.6,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.9,77.9,,,58.4,89.8,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.3,34.3,,,29.2,39.8,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.4,15.4,,,13.9,17.2,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.1,73.1,,,59.7,83.2,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.2,75.2,,,53.9,88.7,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.2,76.2,,,62.8,85.8,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.0,86.0,,,73.6,93.1,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.4,47.4,,,41.8,53.1,Gender,Female,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.2,30.2,,,22.6,39.0,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,59.1,59.1,,,52.8,65.1,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,61.0,61.0,,,52.6,68.7,Gender,Male,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.9,5.9,,,5.2,6.8,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.5,15.5,,,13.9,17.3,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.2,76.2,,,63.1,85.8,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MA,Massachusetts,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.5,34.5,,,27.8,41.7,Gender,Female,,,,,POINT (-72.08269067499964 42.27687047000046),,25,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.5,44.5,,,36.2,53.1,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.7,70.7,,,56.8,81.5,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MD,Maryland,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.7,28.7,,,21.7,36.8,Gender,Male,,,,,POINT (-76.60926011099963 39.29058096400047),,24,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.8,50.8,,,44.6,57.0,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.5,38.5,,,32.9,44.3,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.6,8.6,,,7.4,10.0,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.4,79.4,,,70.6,86.1,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.3,90.3,,,84.0,94.3,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.6,43.6,,,37.8,49.5,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.8,78.8,,,71.9,84.4,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,17.0,17.0,,,15.4,18.7,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.7,51.7,,,45.9,57.4,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.0,79.0,,,69.0,86.5,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,16.1,16.1,,,14.7,17.5,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.5,90.5,,,85.0,94.1,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.2,38.2,,,28.7,48.7,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.1,78.1,,,71.6,83.4,Gender,Female,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.2,34.2,,,26.3,43.1,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.2,78.2,,,67.3,86.1,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.7,76.7,,,65.3,85.1,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.6,36.6,,,28.5,45.5,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ME,Maine,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.3,40.3,,,31.2,50.1,Gender,Male,,,,,POINT (-68.98503133599962 45.254228894000505),,23,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.8,39.8,,,31.4,48.8,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.0,40.0,,,31.8,48.8,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.1,15.1,,,13.7,16.6,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.1,87.1,,,77.9,92.9,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.8,80.8,,,69.1,88.8,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,68.2,68.2,,,58.7,76.4,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.1,40.1,,,32.5,48.2,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.6,84.6,,,77.6,89.7,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.0,40.0,,,31.9,48.6,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.4,67.4,,,57.1,76.3,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.4,8.4,,,7.3,9.6,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.9,84.9,,,77.7,90.1,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.7,47.7,,,41.9,53.5,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.8,41.8,,,36.0,47.9,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.2,8.2,,,7.1,9.4,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.1,46.1,,,40.3,52.1,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.0,86.0,,,75.8,92.3,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.2,80.2,,,68.4,88.3,Gender,Male,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MI,Michigan,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.3,39.3,,,33.4,45.6,Gender,Female,,,,,POINT (-84.71439026999968 44.6613195430005),,26,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.2,6.2,,,5.6,6.9,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.4,82.4,,,72.7,89.2,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.0,76.0,,,68.4,82.3,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.1,40.1,,,35.4,45.0,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.8,48.8,,,42.1,55.5,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.8,90.8,,,85.0,94.5,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.1,75.1,,,67.1,81.7,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.6,38.6,,,34.2,43.3,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.4,55.4,,,50.4,60.2,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,91.2,91.2,,,85.9,94.7,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.0,75.0,,,63.8,83.5,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,29.4,42.9,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.3,55.3,,,50.3,60.2,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.7,82.7,,,73.2,89.3,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.6,11.6,,,10.7,12.6,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.0,49.0,,,42.4,55.7,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.2,6.2,,,5.5,6.9,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.3,11.3,,,10.4,12.2,Gender,Female,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.9,75.9,,,63.5,85.0,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MN,Minnesota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.3,36.3,,,29.9,43.3,Gender,Male,,,,,POINT (-94.79420050299967 46.35564873600049),,27,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.1,7.1,,,6.0,8.2,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.4,46.4,,,40.0,52.9,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.2,42.2,,,35.6,49.1,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.2,70.2,,,55.2,81.9,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.5,87.5,,,74.5,94.4,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.9,39.9,,,31.4,49.1,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.4,86.4,,,70.4,94.5,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.2,7.2,,,6.1,8.4,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.6,35.6,,,27.5,44.6,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,68.0,68.0,,,51.8,80.7,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.5,70.5,,,59.2,79.8,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.5,81.5,,,69.3,89.6,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.8,36.8,,,28.4,46.2,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.7,11.7,,,10.5,12.9,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.5,38.5,,,30.2,47.6,Gender,Male,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.3,40.3,,,34.0,47.0,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.1,46.1,,,39.8,52.6,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.5,6.5,,,5.5,7.7,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.9,80.9,,,69.1,88.9,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.1,12.1,,,10.8,13.5,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MO,Missouri,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.5,70.5,,,59.8,79.3,Gender,Female,,,,,POINT (-92.56630005299968 38.635790776000476),,29,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.2,37.2,,,29.3,45.9,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.3,28.3,,,21.0,37.1,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.2,7.2,,,5.6,9.3,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.0,36.0,,,28.1,44.8,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.1,66.1,,,52.4,77.6,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.4,67.4,,,54.5,78.2,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.5,29.5,,,21.9,38.3,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.4,12.4,,,10.7,14.3,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,20.6,20.6,,,12.5,32.2,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,66.3,66.3,,,52.9,77.5,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,66.4,66.4,,,52.8,77.7,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.4,12.4,,,10.7,14.4,Gender,Female,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.8,27.8,,,17.5,41.0,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,18.7,18.7,,,10.9,30.2,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,63.7,63.7,,,56.0,70.8,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MS,Mississippi,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.5,30.5,,,19.3,44.7,Gender,Male,,,,,POINT (-89.53803082499968 32.745510099000455),,28,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.4,77.4,,,67.1,85.2,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,95.3,95.3,,,89.4,98.0,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.5,45.5,,,37.9,53.2,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.9,41.9,,,34.4,49.8,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.0,77.0,,,61.5,87.5,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.0,69.0,,,54.7,80.4,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.6,40.6,,,33.2,48.5,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.9,12.9,,,11.5,14.6,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.5,44.5,,,37.0,52.4,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.0,79.0,,,64.2,88.8,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.2,73.2,,,60.5,83.0,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.5,37.5,,,27.9,48.3,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.8,34.8,,,26.0,44.9,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.2,13.2,,,11.6,15.0,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,77.6,77.6,,,67.3,85.4,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.5,37.5,,,27.8,48.3,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.2,35.2,,,26.6,44.9,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,95.4,95.4,,,89.7,98.0,Gender,Female,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,MT,Montana,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.8,6.8,,,5.7,8.1,Gender,Male,,,,,POINT (-109.42442064499971 47.06652897200047),,30,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.7,42.7,,,34.0,52.0,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,69.7,69.7,,,54.6,81.5,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.7,45.7,,,37.4,54.2,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,89.7,89.7,,,79.1,95.3,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.0,5.0,,,4.0,6.2,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,89.0,89.0,,,77.9,94.9,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.9,70.9,,,56.9,81.8,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.8,40.8,,,29.3,53.3,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.1,32.1,,,21.4,45.1,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.0,12.0,,,10.4,13.7,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.2,39.2,,,27.8,51.9,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.4,34.4,,,22.7,48.3,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.0,12.0,,,10.4,13.8,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.2,45.2,,,37.0,53.5,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.6,40.6,,,31.5,50.3,Gender,Female,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NC,North Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.1,5.1,,,4.1,6.3,Gender,Male,,,,,POINT (-79.15925046299964 35.466220975000454),,37,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.3,86.3,,,74.7,93.0,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.2,76.2,,,64.7,84.8,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.3,81.3,,,69.9,89.1,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.2,45.2,,,34.9,55.9,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.7,55.7,,,46.0,65.1,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.5,49.5,,,39.1,59.9,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.5,7.5,,,6.3,9.0,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.6,76.6,,,65.1,85.1,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.4,39.4,,,28.9,50.9,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,47.3,47.3,,,37.4,57.4,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.2,82.2,,,69.8,90.3,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.6,9.6,,,8.1,11.2,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.3,39.3,,,28.5,51.3,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,9.3,9.3,,,7.9,10.8,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.0,54.0,,,43.7,63.9,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.5,7.5,,,6.3,8.9,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.4,85.4,,,74.2,92.2,Gender,Male,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.2,82.2,,,69.9,90.2,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,ND,North Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.4,48.4,,,39.3,57.6,Gender,Female,,,,,POINT (-100.11842104899966 47.47531977900047),,38,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.6,81.6,,,69.6,89.6,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.8,5.8,,,5.0,6.7,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.1,9.1,,,7.5,11.0,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.2,45.2,,,33.7,57.1,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.8,82.8,,,74.8,88.7,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,87.4,87.4,,,79.6,92.5,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,18.6,18.6,,,12.1,27.5,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,59.0,59.0,,,52.7,65.0,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,43.1,43.1,,,37.0,49.6,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.8,80.8,,,71.0,87.9,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.8,8.8,,,7.4,10.4,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,21.9,21.9,,,14.2,32.3,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.6,45.6,,,34.7,57.0,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.7,10.7,,,9.7,11.7,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.3,15.3,,,13.6,17.1,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.1,44.1,,,38.0,50.4,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,59.4,59.4,,,53.2,65.4,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,68.8,68.8,,,60.2,76.2,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,91.4,91.4,,,87.2,94.4,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.6,15.6,,,13.7,17.7,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.2,81.2,,,72.2,87.8,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.6,90.6,,,86.0,93.8,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.6,85.6,,,76.6,91.6,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.7,69.7,,,61.3,76.9,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.1,44.1,,,36.4,52.2,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.2,44.2,,,35.8,52.9,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.4,31.4,,,23.8,40.2,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.0,80.0,,,69.5,87.5,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.4,40.4,,,32.3,49.1,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,53.3,53.3,,,45.6,60.9,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.2,44.2,,,35.9,52.8,Gender,Female,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.7,5.7,,,5.0,6.6,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NH,New Hampshire,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.1,82.1,,,68.5,90.6,Gender,Male,,,,,POINT (-71.50036091999965 43.65595011300047),,33,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,9.9,12.1,Gender,Female,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NE,Nebraska,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.3,74.3,,,63.6,82.7,Gender,Male,,,,,POINT (-99.36572062299967 41.6410409880005),,31,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.4,51.4,,,43.3,59.4,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.6,5.6,,,4.8,6.6,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.8,79.8,,,67.3,88.3,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.6,76.6,,,63.1,86.3,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.7,75.7,,,61.0,86.1,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.6,5.6,,,4.7,6.6,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.1,51.1,,,43.4,58.6,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.4,32.4,,,24.7,41.1,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.3,82.3,,,71.0,89.8,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.0,12.0,,,10.6,13.6,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.4,29.4,,,20.5,40.4,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.4,79.4,,,67.4,87.8,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.8,53.8,,,43.1,64.2,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.9,66.9,,,52.6,78.6,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,66.8,66.8,,,52.9,78.4,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.4,54.4,,,44.1,64.3,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.5,30.5,,,21.3,41.6,Gender,Male,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.8,75.8,,,61.7,85.9,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NJ,New Jersey,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.6,12.6,,,11.0,14.3,Gender,Female,,,,,POINT (-74.27369128799967 40.13057004800049),,34,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.5,90.5,,,84.2,94.4,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.7,45.7,,,38.0,53.7,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,76.0,76.0,,,65.7,84.0,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.1,46.1,,,38.3,54.0,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.6,6.6,,,5.5,7.9,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.4,14.4,,,12.8,16.2,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.7,75.7,,,60.7,86.3,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.7,49.7,,,42.3,57.1,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.4,49.4,,,41.8,57.0,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.7,65.7,,,47.4,80.2,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.4,14.4,,,12.8,16.1,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.4,35.4,,,25.6,46.5,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.5,73.5,,,57.1,85.3,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,62.3,62.3,,,43.2,78.2,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.1,33.1,,,23.4,44.5,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.6,6.6,,,5.5,8.0,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,90.9,90.9,,,85.1,94.5,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,25.3,48.0,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.4,76.4,,,66.2,84.2,Gender,Female,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NM,New Mexico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.3,33.3,,,23.3,44.9,Gender,Male,,,,,POINT (-106.24058098499967 34.52088095200048),,35,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.8,30.8,,,19.4,45.1,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.2,7.2,,,5.5,9.5,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.2,38.2,,,26.3,51.7,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,60.9,60.9,,,36.2,81.0,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.7,73.7,,,47.3,89.7,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.9,80.9,,,58.9,92.6,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,59.7,59.7,,,39.4,77.1,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.9,34.9,,,22.3,50.0,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.7,35.7,,,22.9,50.9,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.2,7.2,,,5.4,9.5,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.3,39.3,,,23.9,57.2,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.9,35.9,,,20.4,54.9,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.0,11.0,,,8.8,13.7,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.1,11.1,,,8.7,14.0,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,35.0,35.0,,,24.2,47.6,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NV,Nevada,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.1,25.1,,,16.4,36.6,Gender,Female,,,,,POINT (-117.07184056399967 39.493240390000494),,32,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.8,47.8,,,43.8,51.9,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,63.7,63.7,,,55.9,70.9,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.3,7.3,,,6.7,8.0,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,68.5,68.5,,,60.1,75.8,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,12.2,12.2,,,11.4,13.1,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.1,69.1,,,60.5,76.5,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.1,26.1,,,21.5,31.4,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.7,40.7,,,35.2,46.4,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.2,12.2,,,11.4,13.0,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.0,74.0,,,62.7,82.8,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,27.1,27.1,,,22.0,33.0,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.7,40.7,,,35.0,46.6,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.5,73.5,,,62.3,82.2,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.3,46.3,,,42.1,50.5,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,NY,New York,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.4,7.4,,,6.7,8.1,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.8,73.8,,,63.4,82.0,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.1,74.1,,,63.9,82.2,Gender,Male,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,NY,New York,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.4,36.4,,,32.3,40.7,Gender,Female,,,,,POINT (-75.54397042699964 42.82700103200045),,36,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.0,70.0,,,57.3,80.2,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.3,14.3,,,13.0,15.6,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,85.5,85.5,,,74.3,92.3,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,71.9,71.9,,,60.1,81.3,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.6,44.6,,,39.2,50.2,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.6,84.6,,,72.2,92.1,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.9,84.9,,,77.4,90.2,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,70.1,70.1,,,60.9,77.8,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.4,34.4,,,26.7,42.9,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.9,45.9,,,40.5,51.4,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.9,6.9,,,6.0,7.8,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.9,6.9,,,6.1,7.9,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,85.4,85.4,,,76.8,91.1,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.4,72.4,,,62.6,80.5,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.8,33.8,,,26.6,41.8,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.2,38.2,,,30.9,46.1,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.7,39.7,,,32.1,47.9,Gender,Male,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.8,13.8,,,12.6,15.0,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.7,39.7,,,34.2,45.3,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OH,Ohio,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.7,41.7,,,36.3,47.4,Gender,Female,,,,,POINT (-82.40426005599966 40.06021014100048),,39,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,82.3,82.3,,,72.9,88.9,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.4,84.4,,,74.6,90.8,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.1,41.1,,,34.6,48.0,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.0,30.0,,,21.8,39.8,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,82.3,82.3,,,72.9,88.9,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.1,8.1,,,6.8,9.7,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.4,84.4,,,74.6,90.8,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,24.1,24.1,,,16.8,33.2,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.7,13.7,,,12.1,15.4,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.6,86.6,,,75.4,93.2,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.7,32.7,,,23.2,43.9,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,68.4,68.4,,,53.6,80.3,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.2,8.2,,,6.8,9.7,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.5,13.5,,,12.0,15.1,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.8,23.8,,,16.7,32.8,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.3,86.3,,,74.5,93.1,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,68.2,68.2,,,52.8,80.4,Gender,Male,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.0,32.0,,,25.4,39.3,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.8,41.8,,,34.8,49.1,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OK,Oklahoma,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.6,32.6,,,25.9,40.2,Gender,Female,,,,,POINT (-97.52107021399968 35.47203135600046),,40,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.7,14.7,,,13.1,16.4,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,53.4,53.4,,,46.9,59.6,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.6,7.6,,,6.6,8.9,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.9,46.9,,,39.7,54.2,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.4,74.4,,,61.1,84.4,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,55.2,55.2,,,48.4,61.9,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.8,7.8,,,6.7,9.1,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,93.2,93.2,,,86.6,96.7,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.2,73.2,,,58.2,84.2,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.6,38.6,,,30.2,47.7,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,92.9,92.9,,,86.3,96.5,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,28.2,28.2,,,21.0,36.7,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.5,14.5,,,12.9,16.3,Gender,Female,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.4,39.4,,,30.9,48.6,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,OR,Oregon,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.3,31.3,,,23.0,40.9,Gender,Male,,,,,POINT (-120.15503132599969 44.56744942400047),,41,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.5,12.5,,,11.1,14.1,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.9,79.9,,,63.9,89.9,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,35.7,35.7,,,27.1,45.4,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.5,43.5,,,34.6,52.9,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.2,86.2,,,74.6,93.0,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.2,13.2,,,11.6,15.0,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.0,8.0,,,6.8,9.3,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.6,38.6,,,31.3,46.5,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,83.8,83.8,,,69.8,92.0,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.0,48.0,,,40.6,55.4,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.7,84.7,,,74.1,91.4,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.0,8.0,,,6.8,9.4,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.2,40.2,,,32.7,48.1,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.2,48.2,,,40.7,55.8,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.2,81.2,,,70.3,88.7,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,84.9,84.9,,,74.5,91.5,Gender,Female,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.0,78.0,,,60.2,89.3,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,41.7,41.7,,,33.3,50.6,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PA,Pennsylvania,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,34.2,34.2,,,26.2,43.2,Gender,Male,,,,,POINT (-77.86070029399963 40.79373015200048),,42,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.5,72.5,,,60.9,81.6,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.1,15.1,,,13.4,16.9,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.1,8.1,,,6.5,10.1,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.0,15.0,,,13.4,16.8,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.1,31.1,,,21.9,42.2,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,52.2,52.2,,,40.6,63.6,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.1,14.1,,,12.3,16.1,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,65.9,65.9,,,46.9,80.9,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,51.9,51.9,,,41.3,62.3,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,48.7,48.7,,,34.8,62.7,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,31.6,31.6,,,21.3,44.0,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,53.3,53.3,,,39.7,66.4,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.1,10.1,,,8.4,12.0,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.6,28.6,,,21.9,36.5,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.3,14.3,,,12.5,16.2,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,21.3,21.3,,,15.5,28.5,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,50.8,50.8,,,36.3,65.1,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.0,66.0,,,46.5,81.2,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.7,50.7,,,43.4,58.1,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,52.4,52.4,,,38.4,66.1,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.6,49.6,,,42.2,57.1,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.0,29.0,,,21.8,37.5,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.2,8.2,,,6.6,10.2,Gender,Male,,,,,POINT (-66.590149 18.220833),,72,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,71.9,71.9,,,60.1,81.3,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.1,10.1,,,8.4,12.0,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,PR,Puerto Rico,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,18.3,18.3,,,13.3,24.5,Gender,Female,,,,,POINT (-66.590149 18.220833),,72,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,36.5,36.5,,,25.9,48.7,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.9,6.9,,,5.7,8.3,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,91.5,91.5,,,83.9,95.7,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.6,86.6,,,80.5,91.1,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.8,45.8,,,37.9,53.9,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.4,36.4,,,27.1,46.9,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.9,6.9,,,5.7,8.2,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.0,79.0,,,59.8,90.5,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,29.3,29.3,,,21.2,39.1,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.9,74.9,,,60.9,85.1,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.0,67.0,,,57.7,75.1,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.0,79.0,,,59.5,90.6,Gender,Male,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.1,11.1,,,9.8,12.5,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,76.0,76.0,,,62.6,85.7,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,66.7,66.7,,,56.7,75.4,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.7,33.7,,,27.2,41.0,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.9,79.9,,,69.3,87.5,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,28.1,28.1,,,19.6,38.5,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.9,39.9,,,32.6,47.7,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,19.6,19.6,,,13.2,28.1,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.2,11.2,,,10.0,12.5,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.8,86.8,,,80.4,91.3,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,39.0,39.0,,,30.7,47.9,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.8,90.8,,,82.7,95.4,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,RI,Rhode Island,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,30.8,30.8,,,24.6,37.7,Gender,Female,,,,,POINT (-71.52247031399963 41.70828019300046),,44,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.0,75.0,,,62.5,84.3,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.0,48.0,,,40.6,55.6,Gender,Female,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SC,South Carolina,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,20.1,20.1,,,13.3,29.2,Gender,Male,,,,,POINT (-81.04537120699968 33.998821303000454),,45,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.9,5.9,,,4.2,8.3,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,61.9,61.9,,,42.6,78.1,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.8,40.8,,,21.5,63.5,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.6,88.6,,,70.3,96.2,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.6,84.6,,,69.1,93.1,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.8,5.8,,,4.1,8.1,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.7,37.7,,,23.7,54.1,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,96.6,96.6,,,92.0,98.6,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,60.3,60.3,,,44.1,74.5,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,93.0,93.0,,,80.2,97.7,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,54.4,54.4,,,43.4,65.1,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,10.8,10.8,,,8.7,13.3,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.3,40.3,,,28.6,53.1,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.5,88.5,,,68.7,96.4,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.8,81.8,,,63.0,92.2,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,96.3,96.3,,,91.8,98.4,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,92.1,92.1,,,78.3,97.4,Gender,Male,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,10.9,10.9,,,8.7,13.6,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.4,54.4,,,41.3,66.9,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,SD,South Dakota,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.6,41.6,,,29.3,55.1,Gender,Female,,,,,POINT (-100.3735306369997 44.353130053000484),,46,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.2,37.2,,,29.5,45.5,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.7,44.7,,,36.8,52.9,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.0,7.0,,,5.7,8.7,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.2,7.2,,,5.7,8.9,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.0,45.0,,,32.8,57.7,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,48.2,48.2,,,34.2,62.5,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.2,81.2,,,70.4,88.7,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,93.0,93.0,,,85.5,96.8,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,45.8,45.8,,,33.7,58.3,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.6,49.6,,,35.9,63.4,Gender,Male,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.4,13.4,,,11.7,15.3,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.8,44.8,,,37.1,52.8,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.3,79.3,,,66.6,88.0,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.5,32.5,,,26.0,39.7,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,92.1,92.1,,,83.2,96.5,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,TN,Tennessee,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.4,13.4,,,11.7,15.3,Gender,Female,,,,,POINT (-85.77449091399967 35.68094058000048),,47,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.1,31.1,,,24.9,38.1,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.4,5.4,,,4.5,6.5,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.3,86.3,,,74.2,93.2,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.3,47.3,,,39.3,55.6,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.6,67.6,,,56.6,77.0,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.2,37.2,,,29.2,45.9,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.6,88.6,,,79.9,93.8,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.4,45.4,,,37.3,53.8,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.2,11.2,,,9.8,12.7,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,89.2,89.2,,,80.7,94.2,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.1,11.1,,,9.7,12.7,Gender,Female,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.0,33.0,,,24.3,43.0,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,26.4,26.4,,,18.0,36.8,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,84.7,84.7,,,72.0,92.2,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.5,5.5,,,4.6,6.6,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,29.4,29.4,,,19.9,41.2,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.7,32.7,,,23.8,43.2,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,TX,Texas,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,80.2,80.2,,,65.7,89.6,Gender,Male,,,,,POINT (-99.42677020599967 31.827240407000488),,48,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,38.4,38.4,**,US estimate/number is based on fewer than 50 states and the District of Columbia,35.7,39.7,Gender,Female,,,,,,,59,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.3,86.3,**,US estimate/number is based on fewer than 50 states and the District of Columbia,84.4,88.7,Gender,Female,,,,,,,59,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,73.6,73.6,,,64.6,81.0,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,11.7,11.7,,,10.6,12.9,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.9,43.9,,,37.7,50.3,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.5,12.5,**,US estimate/number is based on fewer than 50 states and the District of Columbia,12.3,13.5,Gender,Female,,,,,,,59,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,49.3,49.3,,,43.3,55.4,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.0,40.0,**,US estimate/number is based on fewer than 50 states and the District of Columbia,38.4,44.2,Gender,Male,,,,,,,59,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,91.5,91.5,,,85.6,95.1,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.1,40.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,37.6,42.5,Gender,Female,,,,,,,59,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.1,13.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,12.3,13.6,Gender,Female,,,,,,,59,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,23.7,23.7,,,18.1,30.3,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.9,47.9,**,US estimate/number is based on fewer than 50 states and the District of Columbia,45.7,50.8,Gender,Female,,,,,,,59,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.4,73.4,,,64.4,80.8,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,11.7,11.7,,,10.6,12.8,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,91.2,91.2,,,85.1,94.9,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.7,86.7,**,US estimate/number is based on fewer than 50 states and the District of Columbia,84.7,88.9,Gender,Female,,,,,,,59,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.1,74.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,70.0,80.2,Gender,Male,,,,,,,59,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.3,42.3,,,35.7,49.2,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.6,79.6,,,64.7,89.3,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,78.5,78.5,,,63.9,88.3,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.8,79.8,**,US estimate/number is based on fewer than 50 states and the District of Columbia,77.0,82.4,Gender,Male,,,,,,,59,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.1,72.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,69.5,74.8,Gender,Female,,,,,,,59,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,23.5,23.5,,,17.7,30.4,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.2,46.2,**,US estimate/number is based on fewer than 50 states and the District of Columbia,45.2,49.8,Gender,Female,,,,,,,59,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.8,7.8,,,6.9,8.8,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.5,75.5,**,US estimate/number is based on fewer than 50 states and the District of Columbia,72.2,80.1,Gender,Male,,,,,,,59,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.1,32.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,30.5,34.1,Gender,Male,,,,,,,59,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.4,79.4,,,66.3,88.3,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.9,79.9,**,US estimate/number is based on fewer than 50 states and the District of Columbia,78.5,82.7,Gender,Male,,,,,,,59,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,72.3,72.3,**,US estimate/number is based on fewer than 50 states and the District of Columbia,69.0,75.0,Gender,Female,,,,,,,59,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.1,7.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,6.8,7.4,Gender,Male,,,,,,,59,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.5,81.5,,,69.4,89.6,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.0,44.0,,,38.1,50.2,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.2,40.2,**,US estimate/number is based on fewer than 50 states and the District of Columbia,38.1,44.1,Gender,Male,,,,,,,59,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.7,7.7,,,6.8,8.7,Gender,Male,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,UT,Utah,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,50.2,50.2,,,44.5,55.9,Gender,Female,,,,,POINT (-111.58713063499971 39.360700171000474),,49,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,US,United States,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.1,7.1,**,US estimate/number is based on fewer than 50 states and the District of Columbia,6.8,7.4,Gender,Male,,,,,,,59,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,US,United States,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.7,32.7,**,US estimate/number is based on fewer than 50 states and the District of Columbia,30.6,35.9,Gender,Male,,,,,,,59,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.9,67.9,,,52.8,80.0,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,46.5,46.5,,,37.4,55.7,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.9,79.9,,,63.2,90.2,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,34.1,34.1,,,25.5,43.8,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.0,13.0,,,11.8,14.3,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,69.4,69.4,,,54.0,81.4,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.0,80.0,,,63.2,90.4,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.8,42.8,,,36.1,49.8,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.8,49.8,,,43.4,56.3,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.1,13.1,,,11.8,14.5,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.7,88.7,,,81.9,93.2,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,43.5,43.5,,,37.2,50.0,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,50.8,50.8,,,44.6,57.1,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,6.4,6.4,,,5.5,7.4,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,45.4,45.4,,,36.6,54.6,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,87.4,87.4,,,79.7,92.4,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.5,33.5,,,25.0,43.2,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,73.6,73.6,,,63.8,81.6,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.5,74.5,,,63.4,83.1,Gender,Female,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VA,Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,6.5,6.5,,,5.6,7.6,Gender,Male,,,,,POINT (-78.45789046299967 37.54268067400045),,51,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,4.8,4.8,,,2.7,8.3,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,4.9,4.9,,,2.8,8.6,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,5.7,5.7,,,3.3,9.9,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,,,****,Sample size of denominator and/or age group for age-standardization is less than 50 or relative standard error is more than 30%,,,Gender,Female,,,,,POINT (-64.896335 18.335765),,78,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VI,Virgin Islands,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,5.0,5.0,,,2.8,8.8,Gender,Male,,,,,POINT (-64.896335 18.335765),,78,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.4,81.4,,,72.3,88.0,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,51.8,51.8,,,43.4,60.1,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.6,37.6,,,27.8,48.5,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,9.3,9.3,,,7.7,11.1,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.9,75.9,,,61.1,86.4,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,49.5,49.5,,,41.5,57.5,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,41.4,41.4,,,33.2,50.1,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.5,81.5,,,68.5,89.9,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.8,8.8,,,7.4,10.4,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,74.5,74.5,,,59.4,85.4,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,83.3,83.3,,,70.1,91.4,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.8,36.8,,,29.1,45.2,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,47.8,47.8,,,37.4,58.4,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,93.4,93.4,,,87.9,96.5,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,79.9,79.9,,,69.4,87.5,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.3,46.3,,,36.5,56.5,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,39.8,39.8,,,28.9,51.7,Gender,Male,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.6,14.6,,,12.9,16.5,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.9,14.9,,,13.0,17.0,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,VT,Vermont,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,92.8,92.8,,,86.9,96.2,Gender,Female,,,,,POINT (-72.51764079099962 43.62538123900049),,50,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.4,44.4,,,39.0,50.1,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,91.7,91.7,,,86.0,95.3,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,40.3,40.3,,,33.7,47.1,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,13.6,13.6,,,12.5,14.9,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,54.0,54.0,,,48.5,59.4,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.8,81.8,,,72.8,88.4,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,86.0,86.0,,,79.8,90.5,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,44.7,44.7,,,38.8,50.8,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,13.5,13.5,,,12.4,14.7,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.4,55.4,,,49.8,60.9,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,75.5,75.5,,,68.5,81.4,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,81.8,81.8,,,73.0,88.2,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,86.4,86.4,,,80.0,91.0,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.5,7.5,,,6.7,8.4,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,75.4,75.4,,,67.9,81.7,Gender,Female,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,90.9,90.9,,,84.6,94.7,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,40.1,40.1,,,33.4,47.1,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,36.6,36.6,,,29.7,44.1,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.3,37.3,,,30.4,44.7,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WA,Washington,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.4,7.4,,,6.6,8.3,Gender,Male,,,,,POINT (-120.47001078999972 47.52227862900048),,53,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.6,32.6,,,22.5,44.7,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,88.7,88.7,,,79.8,94.0,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,46.1,46.1,,,34.4,58.3,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,78.2,78.2,,,68.4,85.6,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,14.1,14.1,,,12.2,16.2,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,88.9,88.9,,,80.1,94.1,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,77.9,77.9,,,68.1,85.4,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,56.0,56.0,,,47.1,64.5,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,53.0,53.0,,,44.3,61.6,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,14.1,14.1,,,12.3,16.0,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,55.8,55.8,,,46.7,64.6,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,56.4,56.4,,,48.0,64.5,Gender,Female,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,72.3,72.3,,,55.0,84.8,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,71.3,71.3,,,52.5,84.8,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.2,7.2,,,5.9,8.6,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,48.7,48.7,,,37.7,59.8,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,74.9,74.9,,,60.6,85.2,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,70.3,70.3,,,51.1,84.3,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.4,7.4,,,6.2,8.8,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WI,Wisconsin,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,38.1,38.1,,,27.9,49.4,Gender,Male,,,,,POINT (-89.81637074199966 44.39319117400049),,55,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,67.8,67.8,,,54.0,79.1,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,32.6,32.6,,,25.0,41.4,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,15.3,15.3,,,13.9,16.9,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.8,44.8,,,38.6,51.0,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.5,81.5,,,69.1,89.7,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,44.9,44.9,,,38.7,51.4,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,8.7,8.7,,,7.5,10.0,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,67.0,67.0,,,53.6,78.1,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,37.9,37.9,,,31.8,44.4,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.6,80.6,,,72.3,86.9,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,8.8,8.8,,,7.6,10.3,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,32.3,32.3,,,24.4,41.3,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,64.6,64.6,,,55.3,72.9,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,81.3,81.3,,,72.7,87.7,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,33.0,33.0,,,25.1,42.1,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,42.6,42.6,,,36.3,49.3,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.3,31.3,,,23.9,39.8,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.1,80.1,,,67.9,88.5,Gender,Male,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,15.7,15.7,,,14.1,17.5,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST1_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WV,West Virginia,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,64.4,64.4,,,55.7,72.2,Gender,Female,,,,,POINT (-80.71264013499967 38.66551020200046),,54,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.2,33.2,,,24.3,43.4,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,66.4,66.4,,,54.0,76.9,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,33.7,33.7,,,25.2,43.4,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,80.0,80.0,,,68.5,88.0,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,CRDPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,23.3,23.3,,,14.7,34.9,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,12.4,12.4,,,10.4,14.7,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,65.7,65.7,,,53.8,75.9,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,30.6,30.6,,,19.4,44.7,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,79.9,79.9,,,68.3,88.0,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,AGEADJPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,57.0,57.0,,,35.1,76.5,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,CRDPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,31.4,31.4,,,19.2,46.8,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Age-adjusted Prevalence,25.5,25.5,,,15.2,39.5,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Age-adjusted Prevalence,7.1,7.1,,,5.7,8.8,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Crude Prevalence,55.9,55.9,,,34.3,75.4,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,CRDPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,42.5,42.5,,,31.3,54.6,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged 18-64 years with asthma,,%,Crude Prevalence,37.3,37.3,,,27.2,48.7,Gender,Female,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_1,CRDPREV,GENDER,GENF,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Influenza vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,56.9,56.9,,,35.6,75.9,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST5_2,AGEADJPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Current asthma prevalence among adults aged >= 18 years,,%,Crude Prevalence,7.1,7.1,,,5.7,8.8,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST1_1,CRDPREV,GENDER,GENM,,,,
2021,2021,WY,Wyoming,BRFSS,Asthma,Pneumococcal vaccination among noninstitutionalized adults aged >= 65 years with asthma,,%,Age-adjusted Prevalence,55.4,55.4,,,34.5,74.6,Gender,Male,,,,,POINT (-108.10983035299967 43.23554134300048),,56,AST,AST6_2,AGEADJPREV,GENDER,GENM,,,,
